Practice parameter for the assessment and treatment of children and adolescents with autism spectrum disorder.
暂无分享,去创建一个
[1] M. Ferriter,et al. Gluten- and casein-free diets for autistic spectrum disorder. , 2019, The Cochrane database of systematic reviews.
[2] John O. Willis,et al. Asperger Syndrome Diagnostic Scale , 2014 .
[3] C. Mazefsky,et al. The role of emotion regulation in autism spectrum disorder. , 2013, Journal of the American Academy of Child and Adolescent Psychiatry.
[4] D. Lane,et al. Effects of extended release methylphenidate treatment on ratings of attention-deficit/hyperactivity disorder (ADHD) and associated behavior in children with autism spectrum disorders and ADHD symptoms. , 2013, Journal of child and adolescent psychopharmacology.
[5] M. Wagner,et al. Bullying involvement and autism spectrum disorders: prevalence and correlates of bullying involvement among adolescents with an autism spectrum disorder. , 2012, Archives of pediatrics & adolescent medicine.
[6] J. Veenstra-VanderWeele,et al. Diagnostic Yield of Chromosomal Microarray Analysis in an Autism Primary Care Practice: Which Guidelines to Implement? , 2011, Journal of Autism and Developmental Disorders.
[7] M. Siegel,et al. Psychotropic Medications in Children with Autism Spectrum Disorders: A Systematic Review and Synthesis for Evidence-Based Practice , 2012, Journal of autism and developmental disorders.
[8] J. Buitelaar,et al. A randomized double-blind study of atomoxetine versus placebo for attention-deficit/hyperactivity disorder symptoms in children with autism spectrum disorder. , 2012, Journal of the American Academy of Child and Adolescent Psychiatry.
[9] Guido Gerig,et al. Differences in white matter fiber tract development present from 6 to 24 months in infants with autism. , 2012, The American journal of psychiatry.
[10] K. Williams,et al. Intravenous secretin for autism spectrum disorders (ASD). , 2012, The Cochrane database of systematic reviews.
[11] B. Malow,et al. Parental Sleep Concerns in Autism Spectrum Disorders: Variations from Childhood to Adolescence , 2011, Journal of Autism and Developmental Disorders.
[12] Luther G. Kalb,et al. Relationship Status Among Parents of Children with Autism Spectrum Disorders: A Population-Based Study , 2012, Journal of autism and developmental disorders.
[13] J. Baio. Prevalence of autism spectrum disorders--Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008. , 2012, Morbidity and mortality weekly report. Surveillance summaries.
[14] Zachary Warren,et al. A multisite study of the clinical diagnosis of different autism spectrum disorders. , 2012, Archives of general psychiatry.
[15] C. McDougle,et al. Effects of risperidone and parent training on adaptive functioning in children with pervasive developmental disorders and serious behavioral problems. , 2012, Journal of the American Academy of Child and Adolescent Psychiatry.
[16] A. Hayen,et al. Auditory integration training and other sound therapies for autism spectrum disorders (ASD). , 2011, The Cochrane database of systematic reviews.
[17] Katrina Jane Williams,et al. Omega-3 fatty acids supplementation for autism spectrum disorders (ASD). , 2011, The Cochrane database of systematic reviews.
[18] S. Bryson,et al. Recurrence Risk for Autism Spectrum Disorders: A Baby Siblings Research Consortium Study , 2011, Pediatrics.
[19] Kathryn Roeder,et al. Multiple Recurrent De Novo CNVs, Including Duplications of the 7q11.23 Williams Syndrome Region, Are Strongly Associated with Autism , 2011, Neuron.
[20] P. Bearman,et al. Closely Spaced Pregnancies Are Associated With Increased Odds of Autism in California Sibling Births , 2011, Pediatrics.
[21] P. Howlin. A Practical Guide to Autism: What Every Parent, Family Member and Teacher Needs to Know , 2010 .
[22] Matthew W State,et al. The Genetics of Child Psychiatric Disorders: Focus on Autism and Tourette Syndrome , 2010, Neuron.
[23] Клинические дисциплины. Autism Diagnostic Observation Schedule , 2010 .
[24] Leslie G Biesecker,et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. , 2010, American journal of human genetics.
[25] N. Marlow,et al. Autism spectrum disorders in extremely preterm children. , 2010, The Journal of pediatrics.
[26] L. Soorya,et al. Divalproex Sodium vs Placebo for the Treatment of Irritability in Children and Adolescents with Autism Spectrum Disorders , 2010, Neuropsychopharmacology.
[27] F. Volkmar,et al. Social Skills Interventions for Individuals with Autism: Evaluation for Evidence-Based Practices within a Best Evidence Synthesis Framework , 2010, Journal of autism and developmental disorders.
[28] Mohammad Reza Mohammadi,et al. Double-blind placebo-controlled trial of pentoxifylline added to risperidone: Effects on aberrant behavior in children with autism , 2010, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[29] Amy L. Donaldson,et al. Randomized, Controlled Trial of an Intervention for Toddlers With Autism: The Early Start Denver Model , 2010, Pediatrics.
[30] R. Findling,et al. Aripiprazole in the Treatment of Irritability in Children and Adolescents With Autistic Disorder , 2009, Pediatrics.
[31] C. McDougle,et al. Medication and parent training in children with pervasive developmental disorders and serious behavior problems: results from a randomized clinical trial. , 2009, Journal of the American Academy of Child and Adolescent Psychiatry.
[32] R. Mcquade,et al. A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder. , 2009, Journal of the American Academy of Child and Adolescent Psychiatry.
[33] Nasreen Razack-Malik. Autism Spectrum Disorders in Infants and Toddlers: Diagnosis, Assessment, and Treatment , 2009 .
[34] J. Walkup. Practice parameter on the use of psychotropic medication in children and adolescents. , 2009, Journal of the American Academy of Child and Adolescent Psychiatry.
[35] J. Bregman,et al. Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism. , 2009, Archives of general psychiatry.
[36] Kim Har,et al. Cognitive behavioral therapy for anxiety in children with autism spectrum disorders: a randomized, controlled trial. , 2009, Journal of child psychology and psychiatry, and allied disciplines.
[37] C. McDougle,et al. A Double-Blind, Placebo-Controlled Trial of Oral Human Immunoglobulin for Gastrointestinal Dysfunction in Children with Autistic Disorder , 2009, Journal of autism and developmental disorders.
[38] R. Foxx,et al. Applied behavior analysis treatment of autism: the state of the art. , 2008, Child and adolescent psychiatric clinics of North America.
[39] A. Wetherby,et al. Validation of the Infant—Toddler Checklist as a broadband screener for autism spectrum disorders from 9 to 24 months of age , 2008, Autism : the international journal of research and practice.
[40] A. Hardan,et al. Guanfacine in Children with Autism and/or Intellectual Disabilities , 2008, Journal of developmental and behavioral pediatrics : JDBP.
[41] M. Carter,et al. Research on the Efficacy of Sensory Integration Therapy: Past, Present and Future , 2008 .
[42] D. Geschwind,et al. Advances in autism genetics: on the threshold of a new neurobiology , 2008, Nature Reviews Genetics.
[43] M. Ferriter,et al. Gluten- and casein-free diets for autistic spectrum disorder. , 2008, The Cochrane database of systematic reviews.
[44] Pamela J. Crooke,et al. Brief Report: Measuring the Effectiveness of Teaching Social Thinking to Children with Asperger Syndrome (AS) and High Functioning Autism (HFA) , 2008, Journal of autism and developmental disorders.
[45] E. Dirik,et al. Risperidone versus haloperidol in children and adolescents with AD , 2008, European Child & Adolescent Psychiatry.
[46] Richard F. Ittenbach,et al. Disparities in Diagnoses Received Prior to a Diagnosis of Autism Spectrum Disorder , 2007, Journal of autism and developmental disorders.
[47] E. Jones,et al. Teaching spontaneous responses to young children with autism. , 2007, Journal of applied behavior analysis.
[48] Bruce Fireman,et al. Maternal and paternal age and risk of autism spectrum disorders. , 2007, Archives of pediatrics & adolescent medicine.
[49] L. Soorya,et al. Levetiracetam versus placebo in childhood and adolescent autism: a double-blind placebo-controlled study , 2006, International clinical psychopharmacology.
[50] E. Hollander,et al. ADouble-Blind Placebo-Controlled Pilot Study of Olanzapine in Childhood/Adolescent Pervasive Developmental Disorder , 2006 .
[51] L. E. Arnold,et al. Atomoxetine for hyperactivity in autism spectrum disorders: placebo-controlled crossover pilot trial. , 2006, Journal of the American Academy of Child and Adolescent Psychiatry.
[52] L. Lotspeich,et al. A Comparison of Health Care Utilization and Costs of Children With and Without Autism Spectrum Disorders in a Large Group-Model Health Plan , 2006, Pediatrics.
[53] A. Newell. Controversial Therapies for Developmental Disabilities: Fad, Fashion, and Science in Professional Practice , 2006 .
[54] H. L. Wong,et al. Patterns of Complementary and Alternative Medical Therapy Use in Children Diagnosed with Autism Spectrum Disorders , 2006, Journal of autism and developmental disorders.
[55] Richard D. Leiker,et al. Deaths Resulting From Hypocalcemia After Administration of Edetate Disodium: 2003-2005 , 2006, Pediatrics.
[56] W. Stone,et al. A randomized comparison of the effect of two prelinguistic communication interventions on the acquisition of spoken communication in preschoolers with ASD. , 2006, Journal of speech, language, and hearing research : JSLHR.
[57] Janet E. Lainhart,et al. Comorbid Psychiatric Disorders in Children with Autism: Interview Development and Rates of Disorders , 2006, Journal of autism and developmental disorders.
[58] J. Moeschler,et al. Clinical Genetic Evaluation of the Child With Mental Retardation or Developmental Delays , 2006, Pediatrics.
[59] M. B. Parsons,et al. Enhancing job-site training of supported workers with autism: a reemphasis on simulation. , 2006, Journal of applied behavior analysis.
[60] U. Frith,et al. The Weak Coherence Account: Detail-focused Cognitive Style in Autism Spectrum Disorders , 2006, Journal of autism and developmental disorders.
[61] D. Beukelman,et al. Augmentative & Alternative Communication: Supporting Children & Adults With Complex Communication Needs , 2006 .
[62] C. McDougle,et al. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity. , 2005, Archives of general psychiatry.
[63] E. Cook,et al. A double-blind, placebo-controlled study of valproate for aggression in youth with pervasive developmental disorders. , 2005, Journal of child and adolescent psychopharmacology.
[64] L. Soorya,et al. Divalproex sodium vs. placebo in the treatment of repetitive behaviours in autism spectrum disorder. , 2005, The international journal of neuropsychopharmacology.
[65] C. McDougle,et al. Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology. , 2005, The American journal of psychiatry.
[66] Linda A. LeBlanc,et al. Intensive Outpatient Behavioral Treatment of Primary Urinary Incontinence of Children With Autism , 2005 .
[67] Dean Sutherland,et al. Enhancing Early Language in Children with Autism Spectrum Disorders. , 2005 .
[68] Fred R. Volkmar,et al. Issues in the Classification of Autism and Related Conditions , 2005 .
[69] N. Minshew,et al. Neurologic Aspects of Autism , 2005 .
[70] R. Schultz,et al. Functional Neuroimaging Studies of Autism Spectrum Disorders , 2005 .
[71] E. Fombonne. Epidemiological Studies of Pervasive Developmental Disorders , 2005 .
[72] G. Anderson,et al. Neurochemical Studies of Autism , 2005 .
[73] P. Howlin. Outcomes in Autism Spectrum Disorders , 2005 .
[74] G. Baranek,et al. Sensory and Motor Features in Autism: Assessment and Intervention. , 2005 .
[75] W. Stone,et al. Screening for Autism in Young Children , 2005 .
[76] M. Rutter. Genetic Influences and Autism , 2005 .
[77] F. Volkmar,et al. 3. Childhood Disintegrative Disorder , 2005 .
[78] T. Kemper,et al. Neuroanatomic observations of the brain in autism: a review and future directions , 2005, International Journal of Developmental Neuroscience.
[79] Robert Schultz,et al. Three Diagnostic Approaches to Asperger Syndrome: Implications for Research , 2005, Journal of autism and developmental disorders.
[80] M. Rutter,et al. Autism Research: Lessons from the Past and Prospects for the Future , 2005, Journal of autism and developmental disorders.
[81] E. Hollander,et al. A Placebo Controlled Crossover Trial of Liquid Fluoxetine on Repetitive Behaviors in Childhood and Adolescent Autism , 2005, Neuropsychopharmacology.
[82] C. Mellis,et al. Incidence of autism spectrum disorders in children in two Australian states , 2005, The Medical journal of Australia.
[83] A. Zimmerman,et al. Immunity, neuroglia and neuroinflammation in autism , 2005, International review of psychiatry.
[84] E. Goldson. Educating Children with Autism , 2004 .
[85] I. Smith,et al. Risperidone in the Treatment of Disruptive Behavioral Symptoms in Children With Autistic and Other Pervasive Developmental Disorders , 2004, Pediatrics.
[86] F. Volkmar. Autism Spectrum Disorders: A Research Review for Practitioners , 2004 .
[87] Edwin H Cook,et al. Autism as a paradigmatic complex genetic disorder. , 2004, Annual review of genomics and human genetics.
[88] M R Mohammadi,et al. Cyproheptadine in the treatment of autistic disorder: a double‐blind placebo‐controlled trial , 2004, Journal of clinical pharmacy and therapeutics.
[89] W. Thompson,et al. MMR vaccine and autism: an update of the scientific evidence , 2004, Expert review of vaccines.
[90] M. Gernsbacher,et al. Outcome Measures for Clinical Drug Trials in Autism , 2004, CNS Spectrums.
[91] M. Chez,et al. Donepezil hydrochloride: a double-blind study in autistic children , 2003, Journal of Pediatric Neurology.
[92] A. Vickers,et al. Complementary and alternative therapies. , 2003, The Urologic clinics of North America.
[93] J. Constantino,et al. Deficits in reciprocal social behavior in male twins: evidence for a genetically independent domain of psychopathology. , 2003, Journal of the American Academy of Child and Adolescent Psychiatry.
[94] L. Koegel,et al. Teaching Children with Autism Self‐Initiations as a Pivotal Response , 2003 .
[95] Jonathan M. Campbell,et al. Efficacy of behavioral interventions for reducing problem behavior in persons with autism: a quantitative synthesis of single-subject research. , 2003, Research in developmental disabilities.
[96] G. Thomas,et al. Children with autism and peer group support: using ‘circles of friends’ , 2003 .
[97] C. McDougle,et al. Risperidone in children with autism and serious behavioral problems. , 2002, The New England journal of medicine.
[98] S. Malhotra,et al. Childhood disintegrative disorder , 2002, European Child & Adolescent Psychiatry.
[99] P. Bolton,et al. The CAST (Childhood Asperger Syndrome Test) , 2002, Autism : the international journal of research and practice.
[100] P. Camfield,et al. Epileptic Syndromes in Childhood: Clinical Features, Outcomes, and Treatment , 2002, Epilepsia.
[101] S. Leekam,et al. The Diagnostic Interview for Social and Communication Disorders: background, inter-rater reliability and clinical use. , 2002, Journal of child psychology and psychiatry, and allied disciplines.
[102] G. Remington,et al. Clomipramine Versus Haloperidol in the Treatment of Autistic Disorder: A Double-Blind, Placebo-Controlled, Crossover Study , 2001, Journal of clinical psychopharmacology.
[103] B. Leventhal,et al. Double-blind, placebo-controlled study of amantadine hydrochloride in the treatment of children with autistic disorder. , 2001, Journal of the American Academy of Child and Adolescent Psychiatry.
[104] R. Landa,et al. Lamotrigine Therapy for Autistic Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial , 2001, Journal of autism and developmental disorders.
[105] D. Robins,et al. The Modified Checklist for Autism in Toddlers: An Initial Study Investigating the Early Detection of Autism and Pervasive Developmental Disorders , 2001, Journal of autism and developmental disorders.
[106] C. Gillberg,et al. The Asperger Syndrome (and High-Functioning Autism) Diagnostic Interview (ASDI): A Preliminary Study of a New Structured Clinical Interview , 2001, Autism : the international journal of research and practice.
[107] S. Baron-Cohen,et al. The Autism-Spectrum Quotient (AQ): Evidence from Asperger Syndrome/High-Functioning Autism, Malesand Females, Scientists and Mathematicians , 2001, Journal of autism and developmental disorders.
[108] J. Chelly,et al. Two affected boys in a Rett syndrome family , 2000, Neurology.
[109] A. Federico,et al. MECP2 mutation in male patients with non‐specific X‐linked mental retardation , 2000, FEBS letters.
[110] J. Clayton-Smith,et al. Somatic mutation in MECP2 as a non-fatal neurodevelopmental disorder in males , 2000, The Lancet.
[111] F. Volkmar,et al. How unspecified are disorders of children with a pervasive developmental disorder not otherwise specified? A study of social problems in children with PDD-NOS and ADHD , 2000, European Child & Adolescent Psychiatry.
[112] K. Quill. Do-Watch-Listen-Say: Social and Communication Intervention for Children with Autism , 2000 .
[113] B. Handen,et al. Efficacy of Methylphenidate Among Children with Autism and Symptoms of Attention-Deficit Hyperactivity Disorder , 2000, Journal of autism and developmental disorders.
[114] F. Volkmar,et al. Practice parameters for the assessment and treatment of children, adolescents, and adults with autism and other pervasive developmental disorders. American Academy of Child and Adolescent Psychiatry Working Group on Quality Issues. , 1999, Journal of the American Academy of Child and Adolescent Psychiatry.
[115] A Pickles,et al. Autism screening questionnaire: Diagnostic validity , 1999, British Journal of Psychiatry.
[116] H. Zoghbi,et al. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2 , 1999, Nature Genetics.
[117] H. Feldman,et al. Naltrexone and communication skills in young children with autism. , 1999, Journal of the American Academy of Child and Adolescent Psychiatry.
[118] H. Roeyers,et al. Differentiating Attention-Deficit/Hyperactivity Disorder From Pervasive Developmental Disorder Not Otherwise Specified , 1998, Journal of learning disabilities.
[119] S. Ozonoff,et al. Effectiveness of a Home Program Intervention for Young Children with Autism , 1998, Journal of autism and developmental disorders.
[120] R. King. Practice parameters for the psychiatric assessment of children and adolescents. American Academy of Child and Adolescent Psychiatry. , 1997, Journal of the American Academy of Child and Adolescent Psychiatry.
[121] Katie Kemmerer,et al. The Use of Peer Networks Across Multiple Settings to Improve Social Interaction for Students with Autism , 1997 .
[122] M. Wiznitzer,et al. High-Dose Pyridoxine and Magnesium Administration in Children with Autistic Disorder: An Absence of Salutary Effects in a Double-Blind, Placebo-Controlled Study , 1997, Journal of autism and developmental disorders.
[123] Linda A. Hodgdon. Visual Strategies for Improving Communication: Practical Supports for School and Home , 1995 .
[124] K. Pierce,et al. Increasing complex social behaviors in children with autism: effects of peer-implemented pivotal response training. , 1995, Journal of applied behavior analysis.
[125] H. Engeland,et al. Failure of naltrexone hydrochloride to reduce self-injurious and autistic behavior in mentally retarded adults. Double-blind placebo-controlled studies. , 1995, Archives of general psychiatry.
[126] B. Birmaher,et al. Use of methylphenidate in the treatment of children with autistic disorder , 1995, Journal of autism and developmental disorders.
[127] H. Feldman,et al. Naltrexone in young autistic children: a double-blind, placebo-controlled crossover study. , 1995, Journal of the American Academy of Child and Adolescent Psychiatry.
[128] A. Couteur,et al. Autism Diagnostic Interview-Revised: A revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders , 1994, Journal of autism and developmental disorders.
[129] C. Gray,et al. The New Social Story Book , 1994 .
[130] M. Ernst,et al. Naltrexone in autistic children: behavioral symptoms and attentional learning. , 1993, Journal of the American Academy of Child and Adolescent Psychiatry.
[131] J. Rapoport,et al. A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder. , 1993, Archives of general psychiatry.
[132] B. Leventhal,et al. Clonidine Treatment of Hyperactive and Impulsive Children with Autistic Disorder , 1992, Journal of clinical psychopharmacology.
[133] B. Pennington,et al. Executive function deficits in high-functioning autistic individuals: relationship to theory of mind. , 1991, Journal of child psychology and psychiatry, and allied disciplines.
[134] R. Perry,et al. The effects of haloperidol on discrimination learning and behavioral symptoms in autistic children , 1989, Journal of autism and developmental disorders.
[135] M. Wiznitzer,et al. AIDS and the Nervous System , 1988, Neurology.
[136] H. Goldstein,et al. Peer intervention effects on communicative interaction among handicapped and nonhandicapped preschoolers. , 1986, Journal of applied behavior analysis.
[137] S. Baron-Cohen,et al. Does the autistic child have a “theory of mind” ? , 1985, Cognition.
[138] R. Perry,et al. Haloperidol in the treatment of infantile autism: effects on learning and behavioral symptoms. , 1984, The American journal of psychiatry.
[139] S. Reiss,et al. Emotional disturbance and mental retardation: diagnostic overshadowing. , 1982, American journal of mental deficiency.
[140] D A Krug,et al. Behavior checklist for identifying severely handicapped individuals with high levels of autistic behavior. , 1980, Journal of child psychology and psychiatry, and allied disciplines.
[141] E. Schopler,et al. Toward objective classification of childhood autism: Childhood Autism Rating Scale (CARS) , 1980, Journal of autism and developmental disorders.
[142] P. Strain,et al. Effects of peer social initiations on the behavior of withdrawn preschool children. , 1977, Journal of applied behavior analysis.
[143] M. Siegel,et al. Psychiatric hospital treatment of children with autism and serious behavioral disturbance. , 2014, Child and adolescent psychiatric clinics of North America.
[144] Jennifer B. Ganz,et al. A Meta-Analysis of Single Case Research Studies on Aided Augmentative and Alternative Communication Systems with Individuals with Autism Spectrum Disorders , 2011, Journal of Autism and Developmental Disorders.
[145] W. Machalicek,et al. Effects of activity schedules on challenging behavior exhibited in children with autism spectrum disorders: A systematic review , 2012 .
[146] S. Levy,et al. Dietary, Complementary and Alternative Therapies , 2011 .
[147] Brian Reichow,et al. Evidence-based practices and treatments for children with autism , 2011 .
[148] P. Howlin,et al. Systematic review of early intensive behavioral interventions for children with autism. , 2009, American journal on intellectual and developmental disabilities.
[149] Stephen Bauer,et al. What is Asperger syndrome? , 2009, The Journal of practical nursing.
[150] G. B. Schaefer,et al. Genetics evaluation for the etiologic diagnosis of autism spectrum disorders , 2008, Genetics in Medicine.
[151] K. Sofronoff,et al. A Randomized Controlled Trial of a Cognitive Behavioural Intervention for Anger Management in Children Diagnosed with Asperger Syndrome , 2007, Journal of autism and developmental disorders.
[152] J. Baio,et al. Prevalence of Autism Spectrum Disorders: Autism and Developmental Disabilities Monitoring Network, United States, 2006. Morbidity and Mortality Weekly Report. Surveillance Summaries. Volume 58, Number SS-10. , 2009 .
[153] E. Hollander,et al. A double-blind placebo-controlled pilot study of olanzapine in childhood/adolescent pervasive developmental disorder. , 2006, Journal of child and adolescent psychopharmacology.
[154] F. Volkmar,et al. Autism in infancy and early childhood. , 2005, Annual review of psychology.
[155] K. Williams,et al. Intravenous secretin for autism spectrum disorder. , 2005, The Cochrane database of systematic reviews.
[156] R. Paul. Promoting social communication in high functioning individuals with autistic spectrum disorders. , 2003, Child and adolescent psychiatric clinics of North America.
[157] C. McDougle,et al. Research Units on Pediatric Psychopharmacology (RUPP) Autism Network. Background and rationale for an initial controlled study of risperidone. , 2000, Child and adolescent psychiatric clinics of North America.
[158] Fred R. Volkmar,et al. Handbook of autism and pervasive developmental disorders, 2nd ed. , 1997 .
[159] R. King. Practice parameters for the psychiatric assessment of children and adolescents. American Academy of Child and Adolescent Psychiatry. , 1995, Journal of the American Academy of Child and Adolescent Psychiatry.
[160] J. Locascio,et al. Naltrexone in autistic children: a double-blind and placebo-controlled study. , 1990, Psychopharmacology bulletin.
[161] F. Volkmar,et al. Seizure disorders in autism. , 1990, Journal of the American Academy of Child and Adolescent Psychiatry.
[162] F. Volkmar,et al. Handbook of Autism and Pervasive Developmental Disorders , 1987 .
[163] ScienceDirect. Journal of the American Academy of Child & Adolescent Psychiatry , 1987 .
[164] O. I. Lovaas,et al. Teaching Developmentally Disabled Children: The Me Book , 1981 .
[165] L. Kanner. Autistic disturbances of affective contact. , 1968, Acta paedopsychiatrica.